Overview
Creative Testing Solutions (CTS) is a nonprofit laboratory testing organization serving blood centers, hospitals, and healthcare partners across the United States. Operating seven laboratories nationwide, CTS provides donor testing for infectious disease markers, FDA-required plasma testing, and specialty testing for eye, tissue, and organ donors, plus research and development support through sample provision. Clients manage services through the CTS Connect portal. What sets Creative Testing Solutions apart is its scale: more than 900 employees serve over 100 healthcare partners, pairing accredited, high-throughput lab operations with the focus of a mission-driven nonprofit. The goal is to deliver accurate, timely testing that supports life-saving transfusion and treatment programs.
Work here?Claim your company
Simplify's Take
What believers are saying
- CTS appointed Josh Moon COO on January 11, 2026, sharpening execution.
- CTS launched July 2026 newsletters and July 29 IPFA engagement, signaling active client communication.
- CTS says all five labs convert to Grifols Ultrio Plus NAT triplex assay in July.
What critics are saying
- CTS closed its Austin lab in December 2025, eliminating 91 jobs.
- CTS depends on blood and plasma collection volumes; 2026 shortage pressure hits throughput.
- CTS’s seven-facility network creates transfer and compliance risk if one lab underperforms.
What makes Creative Testing Solutions unique
- CTS operates five FDA-registered donor testing labs near major airport hubs.
- CTS added specialized Phoenix plasma testing for HAV and Parvo B19 fractionator requirements.
- CTS serves over 100 healthcare entities and supports blood and plasma safety discussions.
Help us improve and share your feedback! Did you find this helpful?